Xianlin Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xianlin Xu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Fengbao Luo
Third Clinical College of Soochow University, Changzhou, Jiangsu, China.
1 shared publication Hongwei Yao
Department of Urology, The Third Affiliated Hospital of Soochow University Changzhou 213000, Jiangsu, China
1 shared publication- Jian Shi
Department of Urology, The Third Affiliated Hospital of Soochow University, Changzhou, 213000
1 shared publication Lujun Chen
Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University Changzhou 213000, Jiangsu, China
1 shared publicationMin Fan
Department of Urology, The Third Affiliated Hospital of Soochow University Changzhou 213000, Jiangsu, China
1 shared publicationQianfeng Zhuang
Department of Urology, The Third Affiliated Hospital of Soochow University Changzhou 213000, Jiangsu, China
1 shared publication
Latest Publications
- Open Access
- 3 November 2015
- Published by Springer Nature in BMC Nephrology
- Vol. 16 (1) , 1-6
Increased circulating follicular helper T cells with decreased programmed death-1 in chronic renal allograft rejection
Chronic antibody-mediated rejection is a major issue that affects long-term renal allograft survival. Since follicular helper T (Tfh) cells promote the development of antigen-specific B cells in alloimmune responses, we investigated the potential roles of Tfh cells, B cells and their alloimmune-regulating molecules in the pathogenesis of chronic renal allograft rejection in this study. The frequency of Tfh, B cells and the levels of their alloimmune-regulating molecules including chemokine receptor type 5 (CXCR5), inducible T cell co-stimulator (ICOS), programmed death-1 (PD-1), ICOSL, PDL-1 and interleukin-21 (IL-21), of peripheral blood were comparatively measured in 42 primary renal allograft recipients within 1–3 years after transplantation. Among them, 24 patients had definite chronic rejection, while other 18 patients had normal renal function. Tfh-cell ratio was significantly increased with PD-1 down-regulation in the patients with chronic renal allograft rejection, while B cells and the alloimmune-regulating molecules studied did not show any appreciable change in parallel. The patients with chronic renal allograft rejection have a characteristic increase in circulating Tfh cells with a decrease in PD-1 expression. These pathological changes may be a therapeutic target for the treatment of chronic renal allograft rejection and can be useful as a clinical index for monitoring conditions of renal transplant.
- 3 November 2015
- Published by Springer Nature in BMC Nephrology
- Vol. 16 (1) , 1-6
Open AccessIncreased circulating follicular helper T cells with decreased programmed death-1 in chronic renal allograft rejection
Chronic antibody-mediated rejection is a major issue that affects long-term renal allograft survival. Since follicular helper T (Tfh) cells promote the development of antigen-specific B cells in alloimmune responses, we investigated the potential roles of Tfh cells, B cells and their alloimmune-regulating molecules in the pathogenesis of chronic renal allograft rejection in this study. The frequency of Tfh, B cells and the levels of their alloimmune-regulating molecules including chemokine receptor type 5 (CXCR5), inducible T cell co-stimulator (ICOS), programmed death-1 (PD-1), ICOSL, PDL-1 and interleukin-21 (IL-21), of peripheral blood were comparatively measured in 42 primary renal allograft recipients within 1–3 years after transplantation. Among them, 24 patients had definite chronic rejection, while other 18 patients had normal renal function. Tfh-cell ratio was significantly increased with PD-1 down-regulation in the patients with chronic renal allograft rejection, while B cells and the alloimmune-regulating molecules studied did not show any appreciable change in parallel. The patients with chronic renal allograft rejection have a characteristic increase in circulating Tfh cells with a decrease in PD-1 expression. These pathological changes may be a therapeutic target for the treatment of chronic renal allograft rejection and can be useful as a clinical index for monitoring conditions of renal transplant.
- 15 September 2014
- Vol. 7 (10) , 6768-75
B7-H4 expression is correlated with tumor progression and clinical outcome in urothelial cell carcinoma.
To investigate the mRNA and protein levels of B7-H4, a B7 family molecule, in human urothelial cell carcinoma (UCC), to analyze the relationship between B7-H4 protein expression level and pathological stage of UCC, and to examine the potential of B7-H4 as a prognostic factor in UCC. mRNA and protein levels of B7-H4 were measured in pairs of tumor tissues and matched adjacent nontumor tissue obtained from patients with UCC by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and immunohistochemical staining, respectively. Association of the protein level of B7-H4 with pathological tumor stage and the overall survival of UCC patients were also analyzed. B7-H4 mRNA and protein level were significantly higher in UCC tumor tissues compared with adjacent nontumor tissues as assessed by qRT-PCR and immunohistochemical staining, respectively. Higher B7-H4 protein levels were observed in patients with more advanced pathological stage of UCC and were also associated with decreased overall survival of patients with UCC. The findings from this study indicate that B7-H4 has the potential to be an independent prognostic indicator for UCC.
- 15 September 2014
- Vol. 7 (10) , 6768-75
B7-H4 expression is correlated with tumor progression and clinical outcome in urothelial cell carcinoma.
To investigate the mRNA and protein levels of B7-H4, a B7 family molecule, in human urothelial cell carcinoma (UCC), to analyze the relationship between B7-H4 protein expression level and pathological stage of UCC, and to examine the potential of B7-H4 as a prognostic factor in UCC. mRNA and protein levels of B7-H4 were measured in pairs of tumor tissues and matched adjacent nontumor tissue obtained from patients with UCC by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and immunohistochemical staining, respectively. Association of the protein level of B7-H4 with pathological tumor stage and the overall survival of UCC patients were also analyzed. B7-H4 mRNA and protein level were significantly higher in UCC tumor tissues compared with adjacent nontumor tissues as assessed by qRT-PCR and immunohistochemical staining, respectively. Higher B7-H4 protein levels were observed in patients with more advanced pathological stage of UCC and were also associated with decreased overall survival of patients with UCC. The findings from this study indicate that B7-H4 has the potential to be an independent prognostic indicator for UCC.